With the New Year right around the corner, were keeping up our tradition of reviewing what made this past year one to remember in the Diabetes World.
Of course, weve all endured the continuing impact of the COVID-19 pandemic, from overrun hospitals to economic fallout to cancelled in-person events, to delayed timelines on new diabetes devices and product shipping woes worldwide. Its been a lot to navigate, in many ways a continuation of the troubled previous year.
Meanwhile, pretty much everything is still being seen through the lens of this pandemic and a tense political climate in the United States.
Yet there does seem to be hope on the horizon, with vaccine availability and a slowly improving economic situation. In the diabetes arena, we look forward to a resurgence of new product approvals in the near future as the Food and Drug Administration (FDA) regulators get caught up.
Heres a look at the big themes defining 2021 in diabetes:
The pandemic continued to be the biggest story of 2021, in general and for those with diabetes.
The start of the year brought many discussions about state-led vaccination priorities, and how soon people with diabetes would be able to get those shots while they were still in short supply. The new variants with Greek-lettered names Delta and Omicron have renewed concerns about just how quickly we all may find our way past this pandemic.
Remarkably, one of our own in the Diabetes Community was a pivotal part of developing the COVID-19 vaccines. Dr. Drew Weissman at the University of Pennsylvania was one of the researchers who spent years digging into the science behind mRNA vaccines, and hes also lived with type 1 diabetes (T1D) for more than 50 years. As it turns out, Weissmans work has made him one of Times Heroes of the Year for 2021!
As we saw in 2020, the continuing COVID-19 crisis meant most of the planned diabetes events and conferences during 2021 remained virtual or at least in a hybrid format. That included the huge annual American Diabetes Associations 81st Scientific Sessions event that was again all online. One exception was the annual Friends For Life conference at DisneyWorld in Orlando, Florida, which is held each year in July. This year, it happened to fall into a perfectly-timed bubble of summer weather and easing restrictions that allowed this event to be held in person this past summer.
There were a few FDA approvals in 2021 that made headlines: Bigfoot Biomedicals first connected Unity insulin pen system in May, the FreeStyle Libre 2 mobile app in August, and Medtronics new 7-day extended wear infusion set in September.
However, most of the FDA filings are taking longer than expected, lingering in the review process due to pandemic-caused delays with the agency being short-staffed. Clinical trial research for new products was also slowed down and even halted in some cases. The result: many big expected diabetes product approvals did not happen this year.
Many people with diabetes (PWDs) also experienced shipping delays for their needed supplies and medications, tied once again to COVID-19 issues.
Many shared stories online of how their supplies and medications were delayed or not immediately accessible through mail-order and retail pharmacies, as well as third-party distribution companies. Most of this is tied to either supply stock or staffing shortages that have plagued many businesses globally.
In fact, in November 2021, Novo Nordisk actually experienced a brief manufacturing problem and subsequent shipping delays for its insulin brands, leaving many in the United States without immediate access to their life-sustaining insulin before everything was cleared up.
The year brought a milestone in diabetes history: a century since insulin was first discovered in 1921, by a team led by Toronto-based researchers Dr. Frederick Banting and Dr. Charles Best. They began testing insulin in their lab earlier that year and made the critical discovery of isolating insulin in July 1921. It was then first delivered orally into a patient on Dec. 21, 1921. The first-ever patient to receive an insulin injection came on Jan. 15, 1922, with 15-year-old Leonard Thompson. The rest is history, as they say.
For this century mark, many advocacy initiatives, awareness campaigns, and fundraising efforts have embraced the 100th insulin anniversary theme. One of those included the World Health Organization (WHO) that developed a Global Diabetes Compact to advocate on the need for affordable insulin.
Unfortunately, the current state of insulin affordability or lack thereof clouds this 100th anniversary. Many media outlets have published stories through this milestone year highlighting the insulin pricing crisis here in the United States.
Our Diabetes Community did see some changes materialize, but they only ever seem to be incremental improvements rather than full-scale price-lowering measures that help everyone.
Aside from those big themes of 2021, a number of other notable diabetes-related news stories captured headlines throughout the year:
Several new formulations of basal (long-lasting, background) insulins made headlines throughout the year.
A number of news items touched on digital diabetes data. A big one came in July as the FDA cleared continuous glucose monitor (CGM) company Dexcom to release its real-time API, allowing other companies to directly tie Dexcom CGM data into their devices. Garmin was the first to do so, and the open-source Sugarmate platform (now owned by Tandem Diabetes Care) took a hiatus before finally returning later in the year.
The medical establishment made a landmark embrace of do-it-yourself (DIY) technology in the diabetes space, with an international consensus statement being published in The Lancet Diabetes & Endocrinology. This is the first-of-its-kind guidance for healthcare providers on treating patients using DIY diabetes systems.
The authors noted that healthcare providers should facilitate and support people with diabetes who choose this DIY tech to automate their insulin delivery systems, and work with patients to set realistic goals and minimize any risk. They also called for local policies supporting open-source closed loop systems as fostering ethical medical principles and evidence-based medical treatment.
#WeAreNotWaiting for the win!
From beginning to end, diabetes was certainly on display this year for people around the world to get a glimpse of:
Nick Jonas in his CGM Super Bowl ad
Our Diabetes Community sadly said goodbye to some incredible people and advocates in 2021, whove made a mark on our community and world for the better:
Erin Gilmer a diabetes and disability rights advocate, passed away at 38 years old in July. As the New York Times reports, Gilmer fought for a more compassionate healthcare system, bringing an extensive knowledge of policy and even more extensive firsthand experience as a patient.
Scott Strange this longtime T1D advocate and blogger passed away in early November, at 58 years old. He volunteered at many advocacy conferences and meetings, and generously gave much of himself to people with diabetes over his impressive 50+ years of living with this condition. In particular, he wrote a lot about mental health with diabetes and gave many within the community a voice for sharing their own stories and struggles on the mental health front.
Thom Scher the 33-years-young president and CEO of leading diabetes nonprofit Beyond Type 1 surprisingly passed away in early December in New York City. Scher did not live with diabetes himself, but was a passionate advocate who had a bold vision to challenge the status quo in terms of what a nonprofit organization could do. He led Beyond Type 1 to serve people living with both T1D and type 2 diabetes, providing resources to this community in multiple languages all over the world.
Anne Rice the famous Vampire novel author who was extremely public about her diabetes diagnosis and struggles, died in mid-December at 80 years old. She had struggled with complications of diabetes since her delayed diagnosis in 1998.
These beautiful souls and others lost this year will be sorely missed!
The past year has been tough on so many fronts. Heres to looking forward to a brighter, less stressful 2022 ahead.
NOTE: DiabetesMine appeared on the Diabetes Connections podcast recently, offering a look back at 2021 and a view of Our Diabetes Technology Predictions for 2022. Be sure to check that out, too.
Read the original post:
2021: The Year in Diabetes - Healthline
- Paralysed patient now able to walk as stem cell therapy shows promising results - WION - April 15th, 2024
- Andrew Steele Sees Aging as the Root of Disease - Worth - Worth Magazine - April 15th, 2024
- The astonishing effect of stem cell implants - as groundbreaking treatment 'transforms' life for those with brain damage ... - Daily Mail - April 15th, 2024
- Consumer Alert on Regenerative Medicine Products Including Stem Cells - FDA.gov - April 13th, 2024
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market - Forbes - April 13th, 2024
- Brain-cell transplants are the newest experimental epilepsy treatment - MIT Technology Review - April 3rd, 2024
- Global Regenerative Medicine Market to Touch Valuation of USD 472.95 Billion by 2032, at 25.86% CAGR: Astute ... - Yahoo Finance - April 1st, 2024
- Explosive Growth Projected for Stem Cell Market, Expected to Surpass $37 Billion by 2030 As Revealed In New... - WhaTech - April 1st, 2024
- Integrating New Therapies With Autologous Stem Cell Transplant in Myeloma - Targeted Oncology - April 1st, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - Medical Xpress - March 30th, 2024
- The ISSCR announces 2024 election results - EurekAlert - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Charles River Extends Gene Therapy Alliance with NUS Medicine - Contract Pharma - March 22nd, 2024
- Exciting opportunities in stem cell technology and regenerative biology in Indian healthcare industry - Express Healthcare - March 22nd, 2024
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine - Yahoo Finance - March 22nd, 2024
- Opinion: The revolutionary sickle cell therapies - MSN - March 22nd, 2024
- 10 Years of Kansas Regenerative Medicine Center - KSAL - March 22nd, 2024
- BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership - Diagnostic and Interventional Cardiology - March 17th, 2024
- Cynata Therapeutics' breakthrough in regenerative medicine - Finance News Network - March 17th, 2024
- New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia - GlobeNewswire - March 17th, 2024
- Novel 3D stem cell therapy to treat critical limb ischaemia - Drug Target Review - March 15th, 2024
- Breaking Boundaries: Pharmicell's Bold Vision for Healthcare Transformation and Monumental Growth - The Worldfolio - March 15th, 2024
- CuSTOM Organoid Research Evolving From Tool to Treatment - Research Horizons - Research Horizons - March 15th, 2024
- BioCardia and StemCardia Announce Partnership to Deliver Cell-Gene Therapy for Remuscularization of Heart - Cath Lab Digest - March 15th, 2024
- Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine ... - Business Wire - March 13th, 2024
- Iron restriction keeps blood stem cells young, researchers find - Phys.org - March 13th, 2024
- Vitamin A could have a key role in both stem cell biology and wound healing: Study - Medical Dialogues - March 9th, 2024
- Trends in Stem Cell Transplantation Refusal for Myeloma Treatment - Targeted Oncology - March 7th, 2024
- Stem Cell Therapy Market (CAGR) of 31.1%, Future of Market Size Emerging Technologies and their Impact on ... - Taiwan News - March 7th, 2024
- This Swedish startup wants to reduce the cost, and controversy, around stem cell production - TechCrunch - March 6th, 2024
- Advancing stem cell therapy: The regulatory process to get to clinical trials - The Economic Times - March 6th, 2024
- Transitioning from traditional surgical methods to the innovative use of stem cells - pharmaphorum - March 6th, 2024
- 'Mini organs' are grown from human stem cells taken during the late stages of pregnancy for the first time - m - Daily Mail - March 6th, 2024
- Stem cell transplant cures man of HIV and leukemia, one of five to achieve full remission - Fox 28 - March 3rd, 2024
- Stem Cell Therapy Market to Boost USD 137.5 Billion by 2034 and Projected to grow at 32.10% CAGR with increasing ... - Yahoo Finance - March 1st, 2024
- Studies expand use of stem cell therapies - WPLG Local 10 - March 1st, 2024
- Innovative therapy targets and destroys leukemia stem cells - News-Medical.Net - February 27th, 2024
- Unlocking the Potential of Stem Cells: The Medical Revolution of the Century - EIN News - February 27th, 2024
- Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine ... - Yahoo Finance - February 27th, 2024
- Say Her Name - Henrietta Lacks, The Real Mother Of Stem - Her Campus - February 27th, 2024
- California Man Free of HIV And Cancer in Astonishing Medical Recovery - ScienceAlert - February 25th, 2024
- $93 million for research into improved health for children, young people and the aged, medical devices, mental health ... - Department of Health - February 25th, 2024
- Stem Cells in Regenerative Medicine - PMC - National Center for ... - February 24th, 2024
- The Promise and Reality of Stem Cell Therapy: What You Need to Know - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy: A Beacon of Hope for Patients with Untreatable Conditions - Corporate Wellness Magazine - February 22nd, 2024
- Leading Experts in Stem Cell Therapy: A Global Overview - Corporate Wellness Magazine - February 22nd, 2024
- Can Stem Cells Help Reverse the Effects of Aging? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy for Cancer: Hope on the Horizon? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cells and Autism: A Closer Look at Innovative Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Regrowth and Restoration: The Science Behind Stem Cell Therapy for Hair - Corporate Wellness Magazine - February 22nd, 2024
- Brain Recovery: The Role of Stem Cells in Stroke and Cerebral Palsy Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Turning Back the Clock: The Science of Stem Cells in Anti-Aging - Corporate Wellness Magazine - February 22nd, 2024
- Insights into cellular therapies for cancer treatment - Drug Target Review - February 22nd, 2024
- The Role of Stem Cells in Rheumatoid Arthritis Recovery - Corporate Wellness Magazine - February 22nd, 2024
- Dr Ernesto Romeros vision transforms immunotherapy regenerative medicine into a global leader in stem cell treatment - Khaleej Times - February 22nd, 2024
- World-Renowned Doctors Leading the Way in Stem Cell Research and Treatment - Medical Tourism Magazine - February 20th, 2024
- Choosing the Best: A Guide to America's Premier Stem Cell Therapy Providers - Medical Tourism Magazine - February 20th, 2024
- Navigating Through the Possibilities of Stem Cell Treatment for Eye Disorders - Medical Tourism Magazine - February 20th, 2024
- Global Leaders in Stem Cell Therapy: Where Excellence Meets Innovation - Medical Tourism Magazine - February 20th, 2024
- Excellence in Stem Cell Treatment: How the US is Pioneering Global Healthcare Solutions - Medical Tourism Magazine - February 20th, 2024
- Clarifying Memory Loss Treatments: The Role of Stem Cells - Medical Tourism Magazine - February 20th, 2024
- Battling Inflammation: Stem Cell Therapy for Rheumatoid Arthritis - Medical Tourism Magazine - February 20th, 2024
- Digestive Health and Stem Cells: Treating Ulcerative Colitis and Crohn's Disease - Medical Tourism Magazine - February 20th, 2024
- Top Stem Cell Clinics in the USA: Pioneering Treatments for Chronic Conditions - Medical Tourism Magazine - February 20th, 2024
- Stem Cells and Autism: Understanding the Potential for Innovative Treatments - Medical Tourism Magazine - February 20th, 2024
- Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse - University of Birmingham - February 20th, 2024
- City of Hope Achieves Ground Breaking Treatment for Blood Cancer and HIV - Medriva - February 18th, 2024
- Regenerative Medicine Market Size to Worth USD 95 Billion by 2032 - InvestorsObserver - February 18th, 2024
- North America Organoids Market Projected to Reach US$ 5.35 Billion by 2030, Riding on a CAGR of 21.5% - GlobeNewswire - February 18th, 2024
- Chinese team tests lung treatment that may be first to reverse COPD damage - South China Morning Post - February 15th, 2024
- Why leukemic stem cells not harmed by chemotherapy begin to grow and produce AML cells after treatment - Medical Xpress - February 15th, 2024
- Regenerative Medicine Market is Expected to Reach $49.0 Billion | MarketsandMarkets - Yahoo Finance - February 15th, 2024
- Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells - News-Medical.Net - February 15th, 2024
- Oldest Patient 'Cured' of HIV Still in Remission 5 Years After Transplant for AML - Medpage Today - February 15th, 2024
- Drug used for cocaine addiction may pave way for new treatment of advanced colon cancer - EurekAlert - February 15th, 2024
- Hematopoietic Stem Cells and Their Role in Development and Disease Therapy - The Scientist - February 15th, 2024
- Biomedical Researcher Seeks to Improve Outcomes in Stem Cell Treatments - University of Arkansas Newswire - February 13th, 2024
- Top 3 grants in regenerative medicine: January 2024 - RegMedNet - February 13th, 2024
- Scalise returning to Washington next week with cancer in complete remission - The Hill - February 13th, 2024
- Unlocking the power of stem cell therapy - Drug Target Review - February 9th, 2024
Recent Comments